Tuesday, November 30, 2010

UV Flu Technologies Highlights 2010 Operations as ViraTech UV400 Is

Media coverage of hospital-acquired infections, the swine flu pandemic and antibiotic resistant superbugs is raising consumer awareness and spurring government agencies and businesses to take action to safeguard public health. Demand for products that prevent the spread of airborne illnesses is rising exponentially. The swine flu pandemic created a $7 billion windfall for vaccine manufacturers, according to the Wall Street Journal, and a bonanza for makers of hand sanitizers, who experienced a 129% jump in shipments during last year's flu season

No comments:

Post a Comment